Article
Understanding the interaction of hepatitis C virus with host DEAD-box RNA helicases
1 Jan 2014
Abstract excerpt
The current therapeutic regimen to combat chronic hepatitis C is not optimal due to substantial side effects and the failure of a significant proportion of patients to achieve a sustained virological response. Recently developed direct-acting antivirals targeting hepatitis C virus (HCV) enzymes reportedly increase the virologic response to therapy but may lead to a selection of drug-resistant variants. Besides...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
